Education Featured Article
October 05, 2012
Carbon Credits International Raises $32k for Phillips Brooks School Using its Text-A-Day Product
By Madhubanti Rudra, TMCnet Contributor
Phoenix, AZ-based mobile technology company, Carbon Credits International, recently powered a mobile fundraising campaign for the Phillips Brooks School, an institution known for consistent academic excellence.
Donors used the company’s Text-A-Day mobile commerce and payment platform to donate generously, with an average transaction value of over $700.
The mobile fundraiser was able to accumulate $32,000 in total, proving the effectiveness of Carbon Credits’ Text-A-Day product.
Carbon Credits International operates as a full service mobile marketing agency. Its mobile commerce and communication platform is specifically designed to serve the needs of the not-for-profit community.
Text-A-Day makes any campaign instantly interactive via the mobile phone. This functionality allows the organizations to conduct business transactions, accept donations and engage in targeted communication campaigns with their customers/donors through mobile devices.
"As we have pointed out in the past, this is yet another perfect example of our mobile technology and use of the Text-A-Day product, working hand in hand with an organization to raise more money than they could in the past using only traditional fundraising efforts,” CEO at Carbon Credits International, Greg Lambrecht, noted in a statement.
A few months ago, Carbon Credits International announced that it had forged a partnership with MaestroSoft to add mobile-based technologies to their suite of event management solutions.
Want to learn more about the latest in communications and technology? Then be sure to attend ITEXPO Austin 2012, happening now in Austin, TX. Stay in touch with everything happening at ITEXPO (News - Alert). Follow us on Twitter.
Edited by Braden Becker
LATEST EDUCATION NEWS
California Companies with More Top Women Leaders Associated with Higher Revenue and Profits, UC Davis Graduate School of Management Study Says
U.S. Food and Drug Administration Approves Gilead's Sovaldi™ (Sofosbuvir) for the Treatment of Chronic Hepatitis C